CheapInsurance.com reports that a new $2,000 out-of-pocket cap under Medicare Part D will save millions, but challenges remain in drug pricing and access.
PepGen Inc. has seen its DM1 trials advance to phase 2 with a great reaction from markets. Click here to read my latest analysis on PEPG stock.
Researchers at the UNC School of Medicine and the University of Vermont have developed a more precise way to assess stroke risk in people with atrial fibrillation (A-Fib), a condition that affects 10.
All too often I face the problem of how to help my patients who have been successfully treated for breast cancer but are severely affected by post-menopausal symptoms. The worst of these – profoundly ...
Harvard researchers designed a new AI model, PDGrapher. It can identify treatments to restore diseased cells to health. This could have larger impacts on drug discovery. While AI's most common use ...
Fewer than 40% of Medicare beneficiaries with opioid-use disorders receive proper care, study finds In 2022, 52,000 Medicare beneficiaries experienced an opioid overdose, according to the Centers for ...
A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...
Since 2021, New Yorkers have been rightly puzzled by OnPoint NYC, the “safe injection” sites where hard-drug addicts shoot up under medical supervision. After all, drugs like fentanyl and heroin are ...
Here, an application example refers to FEP-SPell-ABFE/testing, which can be used to make sure that you can obtain the consistent results with ours (FEP-SPell-ABFE ...
Q. A while back, your column provided an answer to a man who woke up too early and couldn’t get back to sleep. There are medications that are supposed to help, like sublingual zolpidem. It contains ...
The free Dog Storm Study clinical trial is accepting applications through August. Piper, a Shetland Sheepdog, wears a dog's life vest which helps calm him during thunderstorms. [ Courtesy of ...
Researchers discovered that PTSD may be driven by excess GABA from astrocytes, not neurons. This chemical imbalance disrupts the brain’s ability to forget fear. A new drug, KDS2010, reverses this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results